Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register

Guardo Daniela, MD, Fabio Guolo, MD, Paola Minetto, MD, Marino Clavio, MD, Livia Giannoni, MD, Elisa Coviello, MD, Giordana Pastori, MD, Giulia Rivoli, MD, Filippo Ballerini, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2015) 126 (23): 2601.

https://doi.org/10.1182/blood.V126.23.2601.2601

Published: 2015

Journal Articles

Fludarabine, Cytarabine, Daunoxome Plus Dasatinib Has High Efficacy with an Acceptable Toxicity Profile As Either Consolidation or Salvage Regimen in Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients

Giordana Pastori, MD, Fabio Guolo, MD, Daniela Guardo, MD, Paola Minetto, MD, Marino Clavio, MD, Maurizio Miglino, PhD, Livia Giannoni, MD, Elisa Coviello, MD, Filippo Ballerini, MD, Federica Galaverna, MD, Annalisa Kunkl, PhD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD

Blood (2015) 126 (23): 4908.

https://doi.org/10.1182/blood.V126.23.4908.4908

Published: 2015

Journal Articles

A Novel Synthetic Lethal Approach Targeting SIRT6 in Acute Myeloid Leukemia

Michele Cea, MD, Antonia Cagnetta, MD, Davide Lovera, MD, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Micaela Bergamaschi, MD, Sara Aquino, MD, Fabio Guolo, MD, Paola Minetto, MD, Filippo Ballerini, MD, Letizia Canepa, MD, Sophia Adamia, PhD, Alessio Nencioni, Ivana Pierri, MD, Marino Clavio, Maurizio Miglino, PhD, Marco Gobbi, MD, Roberto Massimo Lemoli, MD

Blood (2015) 126 (23): 1375.

https://doi.org/10.1182/blood.V126.23.1375.1375

Published: 2015

Journal Articles

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Fabio Guolo, MD, Federica Galaverna, MD, Paola Minetto, MD, Livia Giannoni, MD, Chiara Ghiggi, PhD, Marino Clavio, MD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Adalberto Ibatici, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 2029.

https://doi.org/10.1182/blood.V126.23.2029.2029

Published: 2015

Journal Articles

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Carmen Di Grazia, MD, Simona Geroldi, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Nicoletta Colombo, PhD, Elisabetta Tedone, Silvia Luchetti, Teresa Lamparelli, Francesca Gualandi, MD, Adalberto Ibatici, MD, Stefania Bregante, Maria Teresa van Lint, Anna Maria Raiola, Alida Dominietto, MD, Riccardo Varaldo, Federica Galaverna, Anna Ghiso, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 1866.

https://doi.org/10.1182/blood.V126.23.1866.1866

Published: 2015

Journal Articles

Fludarabine, cytarabine and Idarubicin (FLAI-5) with or without Gemtuzumab Ozogamicin Is an Effective and Well Tolerated Regimen for Younger AML Patients: Real Life Data from a Single Center Register

Fabio Guolo, MD, Paola Minetto, MD, Giordana Pastori, MD, Livia Giannoni, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Francesco Trovato, MD, Marcella Bado, MD, Filippo Ballerini, MD, Marino Clavio, MD, Barbara Rebesco, MD, Maurizio Miglino, PhD, Andrea Bacigalupo, MD, Marco Gobbi, MD, Roberto Lemoli, MD

Blood (2014) 124 (21): 2266.

https://doi.org/10.1182/blood.V124.21.2266.2266

Published: 2014

Journal Articles

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Livia Giannoni, MD, Fabio Guolo, MD, Paola Minetto, MD, Federica Galaverna, MD, Chiara Ghiggi, MD, Marino Clavio, MD, Samuele Bagnasco, MD, Carmen Di Grazia, MD, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Daniele Avenoso, MD, Giordana Pastori, MD, Filippo Ballerini, MD, Annalisa Kunkl, PhD, Maurizio Miglino, PhD, Roberto Lemoli, MD, Marco Gobbi, MD, Andrea Bacigalupo, MD

Blood (2014) 124 (21): 1027.

https://doi.org/10.1182/blood.V124.21.1027.1027

Published: 2014

Journal Articles

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Paola Minetto, MD, Fabio Guolo, MD, Marino Clavio, MD, Laura Mitscheunig, Raffaella Grasso, PhD, Nicoletta Colombo, PhD, Enrico De Astis, MD, Daniele Avenoso, MD, Livia Giannoni, MD, Giordana Pastori, MD, Lisette Del Corso, MD, Enrico Balleari, MD, Filippo Ballerini, MD, Roberto Lemoli, MD, Marco Gobbi, MD, Maurizio Miglino, PhD

Blood (2014) 124 (21): 5603.

https://doi.org/10.1182/blood.V124.21.5603.5603

Published: 2014

Journal Articles

Combined overexpression of WT1 and BAALC genes May Predict AML evolution in MDS Patients

Daniele Avenoso, MD, Enrico De Astis, MD, Nicoletta Colombo, Raffaella Grasso, PhD, Micaela Bergamaschi, MD, Paola Minetto, MD, Sara Aquino, PHD, Davide Lovera, MD, Fabio Cruciani, MD, Fabio Guolo, MD, Filippo Ballerini, PHD, Marino Clavio, MD, Letizia Canepa, MD, Ivana Pierri, MD, Carlo Marani, MD, Marco Gobbi, MD, Maurizio Miglino, PHD

Blood (2013) 122 (21): 5204.

https://doi.org/10.1182/blood.V122.21.5204.5204

Published: 2013

Journal Articles

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry.

Carlo Marani, MD, Raffaella Grasso, PhD, Nicoletta Colombo, Marino Clavio, MD, Fabio Guolo, MD, Annalisa Kunkl, Livia Giannoni, MD, Giuseppina Fugazza, PhD, Roberto Bruzzone, Mario Sessarego, MD, A. M. Carella, MD, Marco Gobbi, MD, Maurizio Miglino, PhD

Blood (2012) 120 (21): 2535.

https://doi.org/10.1182/blood.V120.21.2535.2535

Published: 2012

Journal Articles

Detection of an Unbalanced Ratio Between WT1 Isoforms in Acute Myeloid Leukemia and Its Correlation with Molecular Abnormalities.

Chiara Calabrese, PhD, Gian Matteo Pica, MD, Enrico Bracco, PhD, Anna Serra, PhD, Francesca Carnuccio, PhD, Sonia Carturan, PhD, Valentina Campia, PhD, Chiara Ghiggi, PhD, Fabio Guolo, PhD, Angelo Michele Carella, MD, Nicoletta Colombo, PhD, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Francesco Frassoni, Giuseppe Saglio, MD, Daniela Cilloni, MD

Blood (2012) 120 (21): 2500.

https://doi.org/10.1182/blood.V120.21.2500.2500

Published: 2012

Journal Articles

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Nicoletta Colombo, Raffaella Grasso, Maurizio Miglino, Marino Clavio, Gianmatteo Pica, MD, Germana Beltrami, Micaela Bergamaschi, Carlo Marani, Antonia Cagnetta, Anna Ghiso, Laura Mitscheunig, Ivana Pierri, Filippo Ballerini, Letizia Canepa, Sara Aquino, Enrico De Astis, Angelo Michele Carella, Marco Gobbi

Blood (2009) 114 (22): 4675.

https://doi.org/10.1182/blood.V114.22.4675.4675

Published: 2009

Journal Articles

Evidence for Increased Bone Marrow Lymphoplasmocytoid Cells and SDF1 Secretion in imatinib Treated CML. Relationship with Clinical/hemathological Response

Ivana Pierri, Silvia Catellani, Francesca Olcese, Raffaella Grasso, Nicoletta Colombo, Marco Gobbi, Alessandro Poggi, Maria Raffaella Zocchi

Blood (2008) 112 (11): 4256.

https://doi.org/10.1182/blood.V112.11.4256.4256

Published: 2008

Journal Articles

Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia

Alida Dominietto, Sarah Pozzi, Maurizio Miglino, Flavio Albarracin, Giovanna Piaggio, Francesca Bertolotti, Raffaella Grasso, Simona Zupo, Anna Maria Raiola, Marco Gobbi, Francesco Frassoni, Andrea Bacigalupo

Blood (2007) 109 (11): 5063–5064.

https://doi.org/10.1182/blood-2007-02-072470

Published: 2007

Journal Articles

Treatment of Minimal Residual Disease (MRD) with Donor Lymphocyte Infusions (DLI) in Acute Leukemia Patients Undergoing an Allogeneic Hemopoietic Stem Cell Transplants (HSCT).

Alida Dominietto, MD, Giovanna Piaggio, MD, Sarah Pozzi, MD, Francesca Bertolotti, MD, Nicoletta Colombo, MD, Raffaella Grasso, MD, Anna Garuti, MD, Gabriella Cirmena, MD, Maurizio Miglino, MD, Anna Maria Raiola, MD, Maria Teresa van Lint, MD, Francesco Frassoni, MD, Marina Podesta’, MD, Andrea Bacigalupo, MD

Blood (2005) 106 (11): 2012.

https://doi.org/10.1182/blood.V106.11.2012.2012

Published: 2005

Journal Articles

Molecular Relapse of Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Can Be Successfully Treated with Donor Lymphocyte Infusions.

Alida Dominietto, md, Anna Maria Raiola, md, Raffaella Grasso, md, Anna Garuti, md, Carmen di Grazia, md, Stefania Bregante, md, Francesca Gualandi, md, Adalberto Ibatici, md, Teresa Lamparelli, md, Maria Teresa van Lint, md, Francesco Frassoni, md, Andrea Bacigalupo, md

Blood (2004) 104 (11): 5122.

https://doi.org/10.1182/blood.V104.11.5122.5122

Published: 2004

NARROW

High Prognostic Value of a 3-Genes Molecular Score in Non-High Risk Acute Promyelocytic Leukemia Treated with AIDA 2000 Protocol: A Retrospective Study from a Regional Register

Fludarabine, Cytarabine, Daunoxome Plus Dasatinib Has High Efficacy with an Acceptable Toxicity Profile As Either Consolidation or Salvage Regimen in Adult Philadelphia Positive Acute Lymphoblastic Leukemia Patients

A Novel Synthetic Lethal Approach Targeting SIRT6 in Acute Myeloid Leukemia

High Predictive Value of Pre Transplant Minimal Residual Disease Assessment By Combining WT1 Expression and Flow Cytometry in Acute Myeloid Leukemia

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Fludarabine, cytarabine and Idarubicin (FLAI-5) with or without Gemtuzumab Ozogamicin Is an Effective and Well Tolerated Regimen for Younger AML Patients: Real Life Data from a Single Center Register

Prognostic Value of Minimal Residual Disease Assessed By WT1 Expression Level and Flow Cytometry in Acute Myeloid Leukemia Patients Undergoing Allogeneic Marrow Transplantation

Combined Assessment of WT1 and BAALC Expression Levels Improves Risk Stratification in Myelodysplastic Syndromes

Combined overexpression of WT1 and BAALC genes May Predict AML evolution in MDS Patients

Minimal Residual Disease After the First Cycle of Chemotherapy in Acute Myeloid Leukemia: A Comparative Study of WT1 RQ-PCR and 4-Color Flow Cytometry.

Detection of an Unbalanced Ratio Between WT1 Isoforms in Acute Myeloid Leukemia and Its Correlation with Molecular Abnormalities.

High WT1 Expression Has An Independent Positive Influence On CR Rate and EFS in Non M3 AML Patients Treated with Chemotherapy.

Evidence for Increased Bone Marrow Lymphoplasmocytoid Cells and SDF1 Secretion in imatinib Treated CML. Relationship with Clinical/hemathological Response

Donor lymphocyte infusions for the treatment of minimal residual disease in acute leukemia

Treatment of Minimal Residual Disease (MRD) with Donor Lymphocyte Infusions (DLI) in Acute Leukemia Patients Undergoing an Allogeneic Hemopoietic Stem Cell Transplants (HSCT).

Molecular Relapse of Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation Can Be Successfully Treated with Donor Lymphocyte Infusions.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only